ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

Advisors Say 10 Percent Payline “Not Tenable;” All NCI Programs Must Share Budget Cuts.

March 31, 2006

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Includes May issue of Business & Regulatory Report.

May 31, 2002

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998